ANL
Price
$1.75
Change
-$0.01 (-0.57%)
Updated
Sep 5 closing price
Capitalization
64.58M
87 days until earnings call
JAZZ
Price
$129.50
Change
+$1.48 (+1.16%)
Updated
Sep 5 closing price
Capitalization
7.86B
59 days until earnings call
Interact to see
Advertisement

ANL vs JAZZ

Header iconANL vs JAZZ Comparison
Open Charts ANL vs JAZZBanner chart's image
Adlai Nortye
Price$1.75
Change-$0.01 (-0.57%)
Volume$27.78K
Capitalization64.58M
Jazz Pharmaceuticals
Price$129.50
Change+$1.48 (+1.16%)
Volume$718.36K
Capitalization7.86B
ANL vs JAZZ Comparison Chart in %
Loading...
ANL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANL vs. JAZZ commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANL is a StrongBuy and JAZZ is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (ANL: $1.75 vs. JAZZ: $129.50)
Brand notoriety: ANL and JAZZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANL: 357% vs. JAZZ: 98%
Market capitalization -- ANL: $64.58M vs. JAZZ: $7.86B
ANL [@Biotechnology] is valued at $64.58M. JAZZ’s [@Biotechnology] market capitalization is $7.86B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANL’s FA Score shows that 1 FA rating(s) are green whileJAZZ’s FA Score has 0 green FA rating(s).

  • ANL’s FA Score: 1 green, 4 red.
  • JAZZ’s FA Score: 0 green, 5 red.
According to our system of comparison, ANL is a better buy in the long-term than JAZZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANL’s TA Score shows that 5 TA indicator(s) are bullish while JAZZ’s TA Score has 6 bullish TA indicator(s).

  • ANL’s TA Score: 5 bullish, 4 bearish.
  • JAZZ’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, JAZZ is a better buy in the short-term than ANL.

Price Growth

ANL (@Biotechnology) experienced а +3.55% price change this week, while JAZZ (@Biotechnology) price change was +1.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

ANL is expected to report earnings on Dec 03, 2025.

JAZZ is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JAZZ($7.86B) has a higher market cap than ANL($64.6M). JAZZ YTD gains are higher at: 5.156 vs. ANL (-34.828).
ANLJAZZANL / JAZZ
Capitalization64.6M7.86B1%
EBITDAN/A372M-
Gain YTD-34.8285.156-675%
P/E RatioN/A15.38-
RevenueN/A4.09B-
Total CashN/A1.67B-
Total DebtN/A5.43B-
FUNDAMENTALS RATINGS
JAZZ: Fundamental Ratings
JAZZ
OUTLOOK RATING
1..100
34
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
PROFIT vs RISK RATING
1..100
95
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
76
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANLJAZZ
RSI
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
58%
Momentum
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
68%
MACD
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
62%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
65%
Advances
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 5 days ago
60%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 28 days ago
56%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
67%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
65%
View a ticker or compare two or three
Interact to see
Advertisement
ANL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SUSB25.300.04
+0.14%
iShares ESG 1-5 Year USD Corp Bd ETF
VPC20.730.02
+0.12%
Virtus Private Credit ETF
CPSM28.170.01
+0.04%
Calamos S&P 500 Str Alt Prt ETF-May
SBIT30.91-1.03
-3.22%
ProShares UltraShort Bitcoin ETF
GUSH23.59-1.05
-4.26%
Direxion Dly S&P Oil&Gs Ex&Prd Bl 2X ETF

ANL and

Correlation & Price change

A.I.dvisor tells us that ANL and NVCT have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANL and NVCT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANL
1D Price
Change %
ANL100%
-0.57%
NVCT - ANL
22%
Poorly correlated
+2.45%
JAZZ - ANL
21%
Poorly correlated
+1.16%
LENZ - ANL
21%
Poorly correlated
+5.16%
RIGL - ANL
20%
Poorly correlated
+3.02%
FTRE - ANL
20%
Poorly correlated
+10.66%
More

JAZZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, JAZZ has been loosely correlated with TECH. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if JAZZ jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JAZZ
1D Price
Change %
JAZZ100%
+1.16%
TECH - JAZZ
43%
Loosely correlated
+2.82%
FTRE - JAZZ
41%
Loosely correlated
+10.66%
DAWN - JAZZ
39%
Loosely correlated
+1.89%
ROIV - JAZZ
39%
Loosely correlated
+2.78%
RGNX - JAZZ
37%
Loosely correlated
+3.08%
More